Alexander Burik, Author at Labiotech.eu

About

Born in Chicago, I grew up close to Frankfurt, Germany. I hold an MSc in Neuroscience from University College London and a BA in Biochemistry from Knox College in the US.
Outside of science-related activities, I enjoy skiing and writing music.

Articles by Alexander Burik

Startup Scout 15 Jun 2018

This Israeli Biotech is Making Cultured Meat More Like the Real Thing

Today, we’re in Ashdod, Israel, visiting Aleph Farms, a biotech that’s making cultured meat grown in a 3D environment that resembles the texture of natural meat. Mission: Founded in 2017, Aleph Farms uses cell samples taken from living cattle to create cultured meat. The cells are then grown in a 3D environment, which can help […]

June 15, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 14 Jun 2018

Device Helps Protect Cereals by Diagnosing Herbicide Resistance in Weeds

Mologic and Newcastle University have launched a diagnostic device that provides rapid information on herbicide resistance for a common weed, which could help cut major losses for the British agricultural industry. The partnership between academia and industry has developed a device that can diagnose herbicide resistance in the blackgrass weed, which could help farmers protect […]

June 14, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 14 Jun 2018

Our Eyes Could Open A Window to Diagnosing Alzheimer’s and Parkinson’s Disease

Spanish researchers have developed a way to diagnose neurodegenerative diseases by analyzing eye movements. The Madrid-based research team and its spin-off company Aura Innovative Robotics have developed a diagnostic test for neurodegenerative disease that tracks a patient’s eye movements and analyzes the data using machine learning. The diagnostic test, called OSCANN Desk, is currently being […]

June 14, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 13 Jun 2018

French Biotech Develops a New Generation of Safer CAR-T Cells

Cellectis is developing a new type of chimeric antigen receptor that could improve the production and safety of CAR-T cell therapies generated from both patient and donor cells. Cellectis, a French biotech focused on developing CAR-T therapies from donor cells, has published a study in the journal Scientific Reports describing technological advances that could improve the […]

June 13, 2018 - 2 minutesmins - By Alexander Burik

Interview 13 Jun 2018

CAR-T Brings Hope for Cancer Patients, But Challenges Lie Ahead

CAR-T cell therapy has been able to effectively treat cancer in some patients for whom all other treatment options were exhausted. However, the technology still has a long road ahead before becoming a widespread treatment option. Philip spoke to Christian Homsy, CEO of Celyad, at our Refresh Meetup in Brussels about the challenges CAR-T cell […]

June 13, 2018 - 5 minutesmins - By Alexander Burik

News and Trends 11 Jun 2018

Danish Biotech Plans Phase II Study to Fight A Rare Eating Disorder

Saniona, a biotech focused on ion channel research, plans to test its lead candidate in a Phase IIa study for the rare eating disorder hypothalamic obesity. Saniona, based in Copenhagen, plans to start a Phase IIa trial testing its product, Tesomet, a combination of tesofensine and metoprolol, in hypothalamic obesity. The study would complement the […]

June 11, 2018 - 2 minutesmins - By Alexander Burik

More News! 8 Jun 2018

The Textile Industry May Soon Turn to Insects to Help Produce Fabrics

German researchers are exploring ways of using chitosan, which is derived from a component of insect skin called chitin, to replace toxic chemicals in the production of textiles. The researchers, who are based at the Fraunhofer Institute for Interfacial Engineering and Biotechnology in Stuttgart, plan to commercialize their technology and are already working with several […]

June 8, 2018 - 2 minutesmins - By Alexander Burik

Startup Scout 8 Jun 2018

This Israeli Biotech Engineers Tobacco Plants to Make Collagen

This week we’re in Ness Ziona, Israel, visiting CollPlant, a biotech that engineers tobacco plants to produce collagen for a variety of uses, including 3D printing and artificial tendons. Mission: CollPlant engineers tobacco plants to express five human genes, which enables the plants to produce recombinant human collagen. The material can be used in different […]

June 8, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 7 Jun 2018

Microbiome Company Enters $534M Deal With Genentech To Develop Treatments for IBD

UK biotech Microbiotica has entered into a multi-year collaboration with Genentech, one of the world’s first biotechs, to develop microbiome-based treatments for inflammatory bowel disease. Microbiotica, based in Cambridge, UK has entered into a collaboration with Genentech that could be worth up to €452M ($534M), a formidable amount in the microbiome space, with an undisclosed […]

June 7, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 6 Jun 2018

German DNA Treatment Reduces Ulcerative Colitis Symptoms

Sterna Biologicals has obtained positive Phase IIa data for an ulcerative colitis treatment that uses DNA to inhibit inflammatory proteins, which could add to the diverse approaches being developed to treat inflammatory bowel disease. Sterna Biologicals, based in Marburg, Germany, has clinical data showing its ulcerative colitis treatment reduced the severity of the disease compared […]

June 6, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 5 Jun 2018

British Researchers Regenerate Tooth Enamel With Biopolymers

Researchers at Queen Mary University London have found a way to grow mineralized materials that can be used to regenerate hard tissue like dental enamel. British researchers have created a material that can be used as an artificial dental enamel to prevent and treat tooth decay or tooth sensitivity. To create the enamel, the scientists […]

June 5, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 5 Jun 2018

French Biotech Raises €40M to Fight Hepatitis B and NASH

Enyo Pharma has completed a Series B financing round to start Phase II trials by the end of this year testing its lead compound in two different forms of liver disease. Enyo Pharma, based in Lyon, has raised €40M from OrbiMed and other investors to start two Phase II trials testing its lead drug candidate […]

June 5, 2018 - 2 minutesmins - By Alexander Burik

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Alexander Burik

About

Articles by Alexander Burik

This Israeli Biotech is Making Cultured Meat More Like the Real Thing

Device Helps Protect Cereals by Diagnosing Herbicide Resistance in Weeds

Our Eyes Could Open A Window to Diagnosing Alzheimer’s and Parkinson’s Disease

French Biotech Develops a New Generation of Safer CAR-T Cells

CAR-T Brings Hope for Cancer Patients, But Challenges Lie Ahead

Danish Biotech Plans Phase II Study to Fight A Rare Eating Disorder

The Textile Industry May Soon Turn to Insects to Help Produce Fabrics

This Israeli Biotech Engineers Tobacco Plants to Make Collagen

Microbiome Company Enters $534M Deal With Genentech To Develop Treatments for IBD

German DNA Treatment Reduces Ulcerative Colitis Symptoms

British Researchers Regenerate Tooth Enamel With Biopolymers

French Biotech Raises €40M to Fight Hepatitis B and NASH

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Alexander Burik

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!